ReviewMolecules (Basel, Switzerland)2025
Recent Progress of Chiral Mesoporous Silica Nanostructures: From Synthesis to Applications.
Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Rational design of click-assembled chiral dendrimers: anticancer activity and molecular dynamics study.RSC advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chiral mesoporous silica nanostructures (MSNs) have emerged as a cutting-edge material in nanotechnology. These nanostructures not only retain the tunable physicochemical properties of traditional MSNs-such as adjustable pore size, high surface area, and excellent biocompatibility-but also exhibit unique functionalities and biological behaviors due to their helical architectures at both molecular and macroscopic levels. This inherent chirality grants chiral MSNs exceptional potential in diverse applications, including chiral catalysis, enantiomeric separation, chiral recognition, and advanced drug delivery systems. Over the past five years, substantial progress has been made in understanding their synthesis mechanisms and practical applications. This review provides a comprehensive analysis of recent advancements in chiral silica nanostructures, with a focus on the synthesis strategies and applications of chiral MSNs. Emphasis is placed on their roles in chiral recognition, drug delivery, chiral separation, nanomedicine, and asymmetric catalysis. By highlighting these developments, this review serves as a roadmap for the rational design and translational applications of chiral silica nanostructures, offering valuable guidance for unlocking their full potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.